SCHEMBL23558458

SCHEMBL23558458

O=C1CC(CCCO)(CCCO)Oc2ccc(-c3nc(-c4cccnc4)co3)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP13 P45452 1/20 0.40
▸ CYP3A4 P08684 1/20 0.35
▸ HSD11B1 P28845 1/20 0.35
▸ HSD17B1 P14061 1/20 0.34
▸ HSD17B2 P37059 1/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ GLA P06280 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ CASP1 P29466 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ CYP11B1 P15538 4/20 0.33
▸ CYP11B2 P19099 4/20 0.33
▸ ACACB O00763 1/20 0.33
▸ CTSD P07339 1/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ TDP2 O95551 1/20 0.32
▸ ENPP3 O14638 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23524236 0.76 NPC1 (0.51) MMP13KDM4EALDH1A1HPGDHSD17B10
SCHEMBL23524204 0.76 NPC1 (0.49) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL23523954 0.74 MAPT (0.49) MMP13KDM4EALDH1A1HPGDHSD17B10
SCHEMBL23558357 0.72 KDM4E (0.37) MMP13HSD17B1HSD17B2KDM4EALDH1A1
SCHEMBL23558464 0.72 ACACB (0.37) HSD17B1HSD17B2ACACBENPP3ENPP1
SCHEMBL23524270 0.72 KDM4E (0.48) CYP3A4KDM4EALDH1A1GLAGAA
SCHEMBL30355355 0.72 KDM4E (0.48) CYP3A4KDM4EALDH1A1GLAGAA
SCHEMBL23558245 0.72 KDM4E (0.46) HSD17B1HSD17B2KDM4EALDH1A1GLA
SCHEMBL23084682 0.72 MAPT (0.51) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL30355619 0.72 MAPT (0.51) KDM4EALDH1A1HPGDHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2023-07-27 — — US disclosed
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 MMP13 3322/4885CYP3A4 4104/4885HSD11B1 1116/4885
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 MMP13 3322/4885CYP3A4 4104/4885HSD11B1 1116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback